{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:56Z","timestamp":1787069036554,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Research Institute Arag\u00f3n and CerTest Biotec S.L."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background and Objectives: Neisseria gonorrhoeae and Chlamydia trachomatis can cause similar clinical syndromes and may coexist in infections. In emergency medicine, empirical treatment targeting both pathogens is often employed, potentially contributing to antibiotic resistance. Gonococcal resistance has emerged against first-line antimicrobials, necessitating prior testing for fluoroquinolone susceptibility. Certest Biotec developed two molecular diagnostic products for simultaneous detection: VIASURE C. trachomatis &amp; N. gonorrhoeae Real-Time PCR Detection Kit and VIASURE Neisseria gonorrhoeae Ciprofloxacin-Resistant Real-Time PCR Detection Kit. To evaluate these products, clinical performance assessments were conducted at the Clinical Microbiology Laboratory of Miguel Servet University Hospital in Zaragoza, Spain. Results and Conclusions: Both VIASURE assays under study demonstrated high clinical sensitivity and specificity compared to reference molecular assays and Sanger sequencing. These kits offer an accurate diagnosis, facilitating appropriate treatment choices while addressing concerns about emerging antibiotic resistance. Methods: A total of 540 clinical samples from 540 patients already characterized as positive or negative for CT and NG by a molecular assay and by antibiotic susceptibility testing for ciprofloxacin using a concentration gradient diffusion method were used for the clinical evaluation. In cases where sensitivity results were unavailable, conventional PCR and Sanger sequencing were employed.<\/jats:p>","DOI":"10.3390\/antibiotics13111011","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T07:04:04Z","timestamp":1730099044000},"page":"1011","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of Chlamydia trachomatis and Neisseria gonorrhoeae (and Its Resistance to Ciprofloxacin): Validation of a Molecular Biology Tool for Rapid Diagnosis and Treatment"],"prefix":"10.3390","volume":"13","author":[{"given":"Mar\u00eda Paz","family":"Peris","sequence":"first","affiliation":[{"name":"Institute for Health Research Aragon, 50009 Zaragoza, Spain"},{"name":"Department of Animal Pathology, Faculty of Veterinary Sciences, Universidad de Zaragoza, 50013 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-8827","authenticated-orcid":false,"given":"Henar","family":"Alonso","sequence":"additional","affiliation":[{"name":"Department of Microbiology Paediatrics Radiology and Public Health, Faculty of Medicine, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-893X","authenticated-orcid":false,"given":"Cristina","family":"Escolar","sequence":"additional","affiliation":[{"name":"Department of Animal Production and Food Science, Faculty of Veterinary Sciences, Universidad de Zaragoza, 50013 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-4414","authenticated-orcid":false,"given":"Alexander","family":"Tristancho-Bar\u00f3","sequence":"additional","affiliation":[{"name":"Institute for Health Research Aragon, 50009 Zaragoza, Spain"},{"name":"Microbiology Unit, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Abad","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-245X","authenticated-orcid":false,"given":"Antonio","family":"Rezusta","sequence":"additional","affiliation":[{"name":"Institute for Health Research Aragon, 50009 Zaragoza, Spain"},{"name":"Microbiology Unit, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-8952","authenticated-orcid":false,"given":"Ana","family":"Milagro","sequence":"additional","affiliation":[{"name":"Institute for Health Research Aragon, 50009 Zaragoza, Spain"},{"name":"Microbiology Unit, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiab116","article-title":"A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease","volume":"224","author":"Hillier","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.5858\/arpa.2020-0118-RA","article-title":"Point-of-Care Testing for Sexually Transmitted Infections: A Review of Recent Developments","volume":"144","author":"Adamson","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_3","first-page":"183","article-title":"Immunopathogenesis of Chlamydial Infections","volume":"412","author":"Murthy","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_4","unstructured":"Taylor, M., Loo, V., and Wi, T. (2018). Report on Global Sexually Transmitted Infection Surveillance 2018, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: Cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.idc.2023.02.007","article-title":"Update on the Epidemiology, Screening, and Management of Chlamydia trachomatis Infection","volume":"37","author":"Hocking","year":"2023","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2013.08.004","article-title":"Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_8","unstructured":"Gal\u00e1n Montemayor, J.C., Lepe Jim\u00e9nez, J.A., Otero Guerra, L., Serra Pladevall, J., and V\u00e1zquez Vald\u00e9s, F. (2023, October 18). Diagnostico Microbiol\u00f3gico de las Infecciones de Transmisi\u00f3n Sexual y Otras Infecciones Genitales. 2019. 24a. Available online: https:\/\/seimc.org\/contenidos\/documentoscientificos\/procedimientosmicrobiologia\/seimc-procedimientomicrobiologia24a.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e920873","DOI":"10.12659\/MSM.920873","article-title":"Progress and Perspectives in Point of Care Testing for Urogenital Chlamydia trachomatis Infection: A Review","volume":"26","author":"Peng","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","article-title":"Neisseria gonorrhoeae host adaptation and pathogenesis","volume":"16","author":"Quillin","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Meyer, T., and Buder, S. (2020). The Laboratory Diagnosis of Neisseria gonorrhoeae: Current testing and future demands. Pathogens, 9.","DOI":"10.3390\/pathogens9020091"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/cid\/ciy584","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology","volume":"67","author":"Miller","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Caruso, G., Giammanco Virruso, R., and Fasciana, T. (2021). Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18031038"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"de Salazar, A., Espadafor, B., Fuentes-L\u00f3pez, A., Barrientos-Dur\u00e1n, A., Salvador, L., \u00c1lvarez, M., and Garc\u00eda, F. (2019). Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222439"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/apm.12902","article-title":"WHO laboratory validation of Xpert\u00ae CT\/NG and Xpert\u00ae TV on the GeneXpert system verifies high performances","volume":"126","author":"Jacobsson","year":"2018","journal-title":"Apmis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.eimc.2015.02.017","article-title":"Comparison of the CT OligoGen kit with cobas 4800 assay for detection of Chlamydia trachomatis","volume":"33","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fasciana, T., Capra, G., Lipari, D., Firenze, A., and Giammanco, A. (2022). Sexually Transmitted Diseases: Diagnosis and Control. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095293"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe: Gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Giacani","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_21","unstructured":"(2021). Guidelines for the Management of Symptomatic Sexually Transmitted Infections, World Health Organization."},{"key":"ref_22","unstructured":"The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) (2024, March 01). Australian STI Management Guidelines for Use in Primary Care. December 2021. Available online: https:\/\/sti.guidelines.org.au\/syndromes\/urethritis-penile\/."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., and Marusza, W. (2022). Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of Neisseria gonorrhoeae. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810499"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41585-019-0206-2","article-title":"Neisseria gonorrhoeae resistance driven by antibiotic use","volume":"16","author":"Dong","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.juro.2010.04.078","article-title":"Emergence and spread of drug resistant Neisseria gonorrhoeae","volume":"184","author":"Deguchi","year":"2010","journal-title":"J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kenyon, C., Laumen, J., and Manoharan-Basil, S. (2021). Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Neisseria Genome. A Viewpoint. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050515"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Maxmen, A. (2017). Untreatable gonorrhoea on the rise worldwide. Nature, 1476\u20134687.","DOI":"10.1038\/nature.2017.22270"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1389450115666141120110724","article-title":"History and epidemiology of antibiotic susceptibilities of Neisseria gonorrhoeae","volume":"16","author":"Shigemura","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkv432","article-title":"Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: Towards genotype-guided antimicrobial therapy","volume":"71","author":"Pond","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcp.15933","article-title":"Pharmacokinetics of oral ciprofloxacin in adult patients: A scoping review","volume":"90","author":"Junkert","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/JCM.03032-15","article-title":"Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae","volume":"54","author":"Hemarajata","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/JCM.01175-11","article-title":"Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil","volume":"49","author":"Uehara","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kivata, M.W., Mbuchi, M., Eyase, F.L., Bulimo, W.D., Kyanya, C.K., Oundo, V., Muriithi, S.W., Andagalu, B., Mbinda, W.M., and Soge, O.O. (2019). gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1439-1"},{"key":"ref_34","unstructured":"(2024, October 23). 5.5.2017; REGULATION (EU) 2017\/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98\/79\/EC and Comission Decision 2010\/227\/EU. Official Journal of the European Union, 2017. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32017R0746."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: Appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/OLQ.0000000000001141","article-title":"Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics","volume":"47","author":"Pol","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/JCM.00855-17","article-title":"Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status","volume":"55","author":"Perera","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2018.12.018","article-title":"A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae","volume":"94","author":"Ellis","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkv366","article-title":"A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility","volume":"71","author":"Buckley","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00365-18","DOI":"10.1128\/JCM.00365-18","article-title":"Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens","volume":"56","author":"Smid","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/jac\/dkab037","article-title":"Neisseria gonorrhoeae antimicrobial resistance in Spain: A prospective multicentre study","volume":"76","author":"Arando","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_42","unstructured":"European Centre for Disease Prevention and Control (2019). Response Plan to Control and Manage the Threat of Multi- and Extensively Drug-Resistant Gonorrhoea in Europe\u20142019 Update, ECDC."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkac366","article-title":"GyrB in silico mining in 27151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility","volume":"78","author":"Golparian","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez, N.O., P\u00e9rez, N.F., and Mart\u00ednez, S.B. (2022). Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility. Diagn. Microbiol. Infect. Dis., 104.","DOI":"10.1016\/j.diagmicrobio.2022.115798"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liu, H., Tang, K., Pham, C.D., Schmerer, M., Kersh, E.N., and Raphael, B.H. (2022). Characterization of a Neisseria gonorrhoeae Ciprofloxacin panel for an antimicrobial resistant Isolate Bank. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264149"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zamora, J., Abraira, V., Muriel, A., Khan, K.S., and Coomarasamy, A. (2006). Meta-DiSc: A software for meta-analysis of test accuracy data. BMC Med. Res. Methodol., 6.","DOI":"10.1186\/1471-2288-6-31"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/11\/1011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:22:11Z","timestamp":1760113331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/11\/1011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["antibiotics13111011"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13111011","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}